Allergen-induced inflammation in the nose: A comparison of acute and repeated low-dose allergen exposure

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 1, 1996, Pages 42-48

  Roquet, A ^a   Ihre, E ^a   Van Hage Hamsten, M ^a   Hallden G ^a   Zetterstrom O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergy; Challenge; Eosinophils; Histamine; Inflammation; Nose

Indexed keywords

ALLERGEN; HISTAMINE; PROTEIN;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; MALE; NOSE LAVAGE; NOSE MUCOSA; PRIORITY JOURNAL; PROVOCATION TEST;

ADULT; BLOOD PROTEINS; CELL COUNT; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HISTAMINE; HUMANS; MALE; NASAL LAVAGE FLUID; NASAL PROVOCATION TESTS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; RIBONUCLEASES;

EID: 0029669936     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04548.x     Document Type: Article

References (24)

1. Juliusson S, Holmberg K, Karlsson G, Enerbäck L, Pipkorn U. Mast cells and mediators in the nasal mucosa after allergen challenge. Effects of four weeks' treatment with topical glucocorticoid. Clin Exp Allergy 1993;23:591-9.
2. Juliusson S, Pipkorn U, Karlsson G, Enerbäck L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992;90:898-909.
3. Naclerio RM, Meier HL, Kagey-Sobota A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
4. Andersson M, Anderson P, Venge P, Pipkorn U. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effect of topical glucocorticosteroid treatment. Allergy 1989;44:342-8.
5. Bascom R, Pipkorn U, Lichtenstein L, Naclerio R. The influx of inflammatory cells into nasal washing during the late response to allergen challenge and effect of systemic corticosteroid. Am Rev Respir Dis 1988;138:406-12.
6. Klementsson H, Venge P, Andersson M, Pipkorn U. Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes. Acta Otolaryngol 1991; 111:776-84.
7. Dahl R, Venge P, Olsson I. Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Allergy 1978;33:211-15.
8. Frick W, Sedgwick J, Busse W. The appearance of hypo-dense eosinophils in antigen-dependent late phase asthma. Am Rev Respir Dis 1989;139:1401-6.
9. Griffin E, Håkansson L, Formgren H, Jörgensen K, Peterson C, Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol 1991; 87 Suppl 2:548-57.
10. Horn BR, Robin E, Theodore J, van Kessel A. Total eosinophilia counts in the management of bronchial asthma. N Engl J Med 1975;292:1152-5.
11. Linder A, Venge P, Deusch H. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis. Allergy 1987;42:583-90.
12. Venge P, Dahl R. Are blood eosinophil number and activity important for the development of the late asthmatic reaction after allergen challenge? Eur Respir J 1989; 2 Suppl 6:430-4.
13. Klementsson H, Andersson M, Baumgarten C, Venge P, Pipkorn U. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy 1990;20:539-47.
14. Halldén G, Andersson U, Hed J, Johansson SGO. A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry. J Immunol Methods 1989;124:103-9.
15. Halldén G, Hed J. The FOG-method - a new approach to detecting activated eosinophils. ACI News 1993;5:139.
16. Hed J, Halldén G. Counts of activated blood eosinophils for monitoring asthma. Allergy 1993;48 Suppl 17:87-93.
17. Ihre E, Zetterström O. Increase in nonspecific bronchial responsiveness after repeated inhalation of low doses of allergen. Clin Exp Allergy 1993;23:298-305.
18. Ihre E, Axelsson IGK, Zetterström O. Late asthmatic reactions and bronchial variability after challenge with low doses of allergen. Clin Exp Allergy 1988;18:557-67.
19. Charlesworth E, Hodd A, Soter N, Kagey-Sobotka A, Norman P, Liechtenstein L. Cutaneous late phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:1519-26.
20. Liu M, Hubbard W, Proud D. Immediate and late inflammatory response to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator and permeability changes. Am Rev Respir Dis 1991;144:51-8.
21. Naclerio R, Proued D, Togias A. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313:65-70.
22. Bousquet J, Chanez P, Campbell AM, et al. Inflammatory processes in asthma. Int Arch Allergy Immunol 1991; 94:227-32.
23. Kagi M, Joller J, Melka H, Wüthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992;185:88-92.
24. Ihre E, Halldén G, Hed J, Zetterström O. Change in eosinophil expression of ECP and its relation to bronchial responsiveness after repeated inhalation of low doses of allergen. In: Ihre E, editor. Physiological changes and eosinophil activation in allergen induced asthma. Thesis, Karolinska Institute, 1993.